Predictors of cure after hepatic resection of colorectal liver metastases: An analysis of actual 5- and 10-year survivors

Journal of Surgical Oncology

Volumn 103, Issue 8, 2011, Pages 796-800

  Chua, Terence C ^a   Saxena, Akshat ^a   Chu, Francis ^a   Zhao, Jing ^a   Morris, David L ^a,b  

^a ST GEORGE HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

colorectal cancer; cure; hepatectomy; liver metastasis; long term survival

Indexed keywords

COLORECTAL CANCER; DISEASE FREE SURVIVAL; FOLLOW UP; LIVER METASTASIS; LIVER RESECTION; OVERALL SURVIVAL; PRIORITY JOURNAL; REVIEW; SURVIVAL TIME;

CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; CRYOSURGERY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES;

EID: 79955699712     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21864     Document Type: Review

References (23)

1. Hurwitz H, Fehrenbacher L, Novotny W, et al.: Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. [see comment]. N Engl J Med 2004; 350: 2335-2342. (Pubitemid 38702844)
2. Saltz LB, Clarke S, Diaz-Rubio E, et al.: Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: A randomized phase III study. J Clin Oncol 2008; 26: 2013-2019.
3. Van Cutsem E, Lang I, D'haens G, et al.: KRAS status and efficacy in the firstline treatment of patients with metastatic colorectal cancer (mCRC) treated with FOLFIRI with or without cetuximab: The CRYSTAL experience. J Clin Oncol 2008; 26: 5s.
4. Bengmark S, Hafstrom L:, The natural history of primary and secondary malignant tumours of the liver. Cancer 1969; 23: 198-202.
5. Fong Y, Kemeny N, Paty P, et al.: Treatment of colorectal cancer: Hepatic metastasis. Semin Surg Oncol 1996; 12: 219-252. (Pubitemid 26255863)
6. Kemeny N, Fata F:, Arterial, portal or systemic chemotherapy for patients with hepatic metastasis of colorectal carcinoma. J Hepatobiliary Pancreat Surg 1999; 6: 39-49.
7. Steele GJ, Ravikumar TS:, Resection of hepatic metastases from colorectal metastases: Biologic perspectives. Ann Surg 1989; 210.
8. Wood CB, Gillis CR, Blumgart LH:, A retrospective study of the natural history of patients with liver metastases from colorectal cancer. Clin Oncol 1976; 2: 285-288.
9. Wagner JS, Adson MA, Van Heerden JA, et al.: The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment. Ann Surg 1984; 199: 502-508. (Pubitemid 14105105)
10. Pawlik TM, Schulick RD, Choti MA:, Expanding criteria for resectability of colorectal liver metastases. Oncologist 2008; 13: 51-64. (Pubitemid 351206696)
11. Elias D, Cavalcanti A, Sabourin JC, et al.: Resection of liver metastases from colorectal cancer: The real impact of the surgical margin. Eur J Surg Oncol 1998; 24: 174-179. (Pubitemid 28260607)
12. Choti MA, Sitzmann JV, Tiburi MF, et al.: Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 2002; 235: 759-766. (Pubitemid 34547293)
13. Abdalla EK, Vauthey JN, Ellis LM, et al.: Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004; 239: 818-825.
14. Nordlinger B, Quilichini MA, Parc R, et al.: Hepatic resection for colorectal liver metastases. Influence on survival of preoperative factors and surgery for recurrences in 80 patients. Ann Surg 1987; 205: 256-263. (Pubitemid 17037048)
15. van Ooijen B, Wiggers T, Meijer S, et al.: Hepatic resections for colorectal metastases in The Netherlands. A multiinstitutional 10-year study. Cancer 1992; 70: 28-34.
16. D'Angelica M, Brennan MF, Fortner JG, et al.: Ninety-six five-year survivors after liver resection for metastatic colorectal cancer. J Am Coll Surg 1997; 185: 554-559. (Pubitemid 127469824)
17. Tomlinson JS, Jarnagin WR, DeMatteo RP, et al.: Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol 2007; 25: 4575-4580. (Pubitemid 350035315)
18. Vigano L, Ferrero A, Tesoriere RL, et al.: Liver, surgery for colorectal metastases: Results after 10 years of follow-up. Long-term survivors, late recurrences, and prognostic role of morbidity. Ann Surg Oncol 2008; 15: 2458-2464.
19. Kemeny N, Huang Y, Cohen AM, et al.: Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 1999; 341: 2039-2048. (Pubitemid 30035952)
20. Allen PJ, Nissan A, Picon AI, et al.: Technical complications and durability of hepatic artery infusion pumps for unresectable colorectal liver metastases: An institutional experience of 544 consecutive cases. J Am Coll Surg 2005; 201: 57-65. (Pubitemid 40840564)
21. Pawlik TM, Scoggins CR, Zorzi D, et al.: Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 2005; 241: 715-724. (Pubitemid 40604917)
22. de Hass RJ, Wicherts DA, Flores E, et al.: R1 resection by necessity for colorectal liver metastases: Is it still a contraindication to surgery ? Ann Surg 2008; 248: 626-637.
23. Gruenberger T, Jourdan JL, Zhao J, et al.: Reduction in recurrence risk for involved or inadequate margins with edge cryotherapy after liver resection for colorectal metastases. Arch Surg 2001; 136: 1154-1157. (Pubitemid 32929343)